WCN26-5640 CLINICAL OUTCOMES OF HEMOPERFUSION USING HA 130 AMONG END STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS IN A TERTIARY HOSPITAL

Read full text Summarise with VIRAT
Authors: HANIFA SOLAIMAN, LINTANG BEDOL
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

End-stage renal disease (ESRD) patients on maintenance hemodialysis (HD) often experience high morbidity and symptom burden due to inadequate clearance of middle molecules, which conventional HD cannot effectively remove. Hemoperfusion (HP) using the HA130 cartridge has emerged as an adjunct therapy designed to enhance toxin removal and improve clinical outcomes. This study aimed to evaluate the clinical and laboratory outcomes of ESRD patients on maintenance HD undergoing adjunctive hemoperfusion with the HA130 cartridge.

Fields of Study & Subjects

Dialysis and Renal Disease Management Acute Kidney Injury Research Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105274–105274
Publication date
25 March 2026
Language
EN